Olema Oncology

Olema Oncology is one of the...

• Russell 3000.

Olema Oncology is a company listed under the stock ticker OLMA (US).

View the org chart displaying its 26 main executives

Most searched biographies at Olema Oncology

• Sean Bohen, President and Chief Executive Officer
• Andy Rappaport, Director
• Cindy Butitta, Director

Popular executive movements at Olema Oncology

• Scott Garland has joined the company as Director  (posted on October 17 2023).

Create your alert
to follow the executive moves at Olema Oncology.

Olema Oncology has 2,284 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• WindRose Health Investors has announced the acquisition of SubjectWell  (posted on May 2 2024).
• Enlaza Therapeutics has just announced a $100 Million fundraising (posted on May 2 2024).
• Endeavor BioMedicines has just announced a $132 Million fundraising (posted on April 25 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Vik Bajaj - Director at Interline Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Olema Oncology

• Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | Olema Oncology
• Olema Oncology Receives FDA Fast Track Designation for OP-1250 for the Treatment of ER+ / HER2- Metastatic Breast Cancer | Olema Oncology
• Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | Olema Oncology
• Olema Oncology and Aurigene Announce Exclusive Collaboration and License Agreement to Discover and Develop Novel Cancer Therapies | Olema Oncology
• Olema Oncology Provides Clinical Update Reflecting Strong Progress Across OP-1250 Development Program | Olema Oncology
• News Releases | Olema Oncology
• News Releases | Olema Oncology
• Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | Olema Oncology
• Olema Oncology to Present at Jefferies Healthcare Conference | Olema Oncology
• Olema Oncology Reports First Quarter 2022 Financial Results and Provides Corporate Update | Olema Oncology
• View more press releases Close

Social media about Olema Oncology

• Olema Oncology on Wikipedia, Google News & Yahoo Finance
• Olema Oncology on LinkedIn, Twitter & YouTube

Contact by email its executives including Sean Bohen

Call Olema Oncology at +1 415...

View the org chart

Register to receive your alert

Report an error